C-reactive Protein–Triglyceride Index Tied to Coronary Severity in H-Type Hypertension
Personalized briefing
Discovery of the day · Diabetes
C-reactive protein–triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with H-type hypertension
Dear Dr.Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes · Cardiology
Discovery of the day
A novel composite biomarker, the C-reactive protein–triglyceride glucose (CRP-TyG) index, has been proposed for detecting the severity of coronary artery disease (CAD) in patients with H-type hypertension across varying glucose metabolic states. The study, published in Cardiovascular Diabetology, demonstrates that combining inflammatory (CRP) and insulin resistance (TyG) markers into a single index significantly enhances the predictive capacity for severe CAD compared to either marker alone, with the effect modified by the patient’s glucose metabolism status. For your clinical practice in diabetic foot care and cardiovascular risk management, this index offers a readily available, cost-effective tool to stratify coronary risk and intensify preventive strategies in the high-risk population of hypertensive patients with dysglycemia, a group in which India has a high and growing burden.
Novelty
92%
Rigor
85%
Significance
90%
Validity
82%
Clarity
88%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
